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Introduction
Diabetes is one of the most prevalent metabolic disorders 
which is associated with several complications in different 
organs (1). This disease is characterized by hyperglycemia 
and disorder of metabolism of carbohydrates, lipids, and 
proteins. Diabetes is one of the most prevalent and costly 
chronic diseases worldwide and is increasing in prevalence 
because of variations in lifestyle and also improved health-
care in communities, leading to enhanced survival (2).
Insulin is one of the hormones contributing differently to 
metabolism and other body processes. Insulin controls 
the storage and metabolism of carbohydrates, proteins, 
and lipids. It also enhances active transfer of glucose from 
tissue cell membrane of lipid and muscle, is involved in 
converting glucose and intracellular free fatty acids into 
reserves of glycogen and triglycerides, increases conver-
sion of hepatic glucose into glycogen, and inhibits glucose 
output from liver. Intravenous administration of insulin 
causes stimulation of growth hormone through decreas-
ing glycemia (3).
Inadequate monitoring of blood sugar, genetic predisposi-
tion including family history, smoking, obesity, physical 
inactivity, hypertension, and hyperlipidemia are some of 
the risk factors for diabetes (4).
Free radicals are chemically active molecules. The produc-
tion of free radicals in cells is a natural process of body 
metabolic reactions. Normally, these radicals are removed 
by the enzymes and antioxidant compounds in the body. 
Lack of balance between contribution of antioxidant de-
fense and increased production of free radicals leads to 
conditions called oxidative stress. The diabetes-derived 
hyperglycemia causes intensified indices of oxidative 
stress such as membrane lipids peroxidation (5). 
Medicinal herbs are considered as a very suitable alterna-
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Introduction: Diabetes is one of the most prevalent metabolic disorders which is associated with 
several complications in different organs. Nowadays, medicinal herbs are being widely used to 
treat diseases. This study was conducted to study the hypoglycemic effect of Satureja montanum 
in diabetic male rats. 
Methods: In this study 42 male Wistar rats were randomly assigned to 7 equal groups including 
control, diabetic control, treatments 1, 2, and 3, metformin-treated diabetic, and healthy 
treated with Satureja montanum. To  induce diabetes streptozotocin (STZ) at 60 mg/kg was 
intraperitoneally (ip) administered. The animals were treated daily with Satureja montanum 
extract (ip) for one week and their blood glucose was measured daily.
Results: Satureja montanum extract could significantly decrease blood glucose. The greatest effect 
of the extract was seen on day 8 at 800 mg/kg (P < 0.001). Satureja montanum extract caused a 
significant increase in serum insulin compared to the control group (P < 0.001).
Conclusion: The findings of this study indicate that Satureja montanum hydroethanolic extract 
is able to significantly decrease blood glucose of diabetic rats possibly with a stimulatory effect on 
beta cells.
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tive to synthetic drugs because of easy access, fewer side 
effects, and less cost. Plant-derived biological substances 
are a subdiscipline of modern pharmacotherapy of diseas-
es (6). Summer savory, scientifically called Satureja mon-
tanum, is a medicinal herb from Lamiaceae.
This genus consists of approximately 30 species, of which 
12 occur in and 8 are exclusively unique to Iran (7). In 
traditional medicine, analgesic and disinfectant properties 
have been mentioned for Satureja montanum (8). Satureja 
montanum is used to treat thoracic diseases, cough, thin-
ness, and rheumatologic and neurological pains (9). Use 
of Satureja montanum leaf extract causes decrease in hy-
percholesterolemia (10). Some studies have demonstrated 
its anti-inflammatory and antimicrobial properties, as 
well (11,12).
Aerial parts of Satureja montanum have many applica-
tions in food and pharmacologic industries and could be 
used as a strong and natural alternative to synthetic anti-
oxidants (13).
Studies have demonstrated that Satureja montanum  ex-
tract protects reproductive system against cyclophospha-
mide toxicity through antioxidant and androgenic activi-
ties and is used as a supplement in patients with hepatitis 
(14). Zeidán-Chuliá et al study demonstrated antioxi-
dant, antimicrobial, and anti-inflammatory properties of 
Satureja montanum  (15).
In light of the significance of study of diabetes and no in-
vestigation of Satureja montanum  hydroalcoholic extract 
on diabetes as a significant and prevalent disease, this 
study was conducted to study the hypoglycemic effect of 
Satureja montanum  extract in diabetic male Wistar rats. 
Materials and methods
Plant preparation and extraction
Satureja montanum  was obtained from the Herbarium 
unit of Agriculture of Jihad Organization of Hamadan 
province and was transferred to laboratory after identi-
fication by a botanist in Agricultural Research Center of 
Hamadan province. After the plants were cleaned, they 
were shadow-dried in air. The leaves were separated and 
pulverized by a meal. Two hundred grams of the obtained 
powder was stored in ethylic alcohol 80% in refrigerator 
for a week. Then the contents were filtered by a filter paper 
and the obtained solution was concentrated by rotary at 
55 rpm at 60°C. After concentration, the resulting extract 
was placed under the hood for two days to completely dry. 
The prepared extract was kept in freezer at -20°C for later 
uses.
Laboratory animals
In this study, 42 animals were kept in Animal House of 
Research Laboratory of Faculty of Sciences, Bu-Ali Sina 
University, Hamadan at 22 ± 2°C under 12 hours dark/
light cycles with free access to water and food. For adapta-
tion to laboratory conditions, the animals were kept in the 
laboratory for one week before the study. The protocol was 
confirmed in Ethical Committee of Bu-Ali Sina Univer-
sity and all ethical standards of animal experimentation 
(National Institutes of Health, 1985) were followed in the 
present study.
The rats were randomly assigned to eight equal groups 
consisting of healthy control, diabetic control intraperito-
neally (i.p) administered with streptozotocin (STZ) at 60 
mg/kg once, healthy group administered with the extract 
at 400 mg/kg, diabetic groups i.p administered with vari-
ous doses of the extract (at 200, 400, and 800 mg/kg) daily 
for 8 days, and diabetic group treated with gavage metfor-
min at 500 mg/kg daily. 
To induce diabetes, STZ (Sigma Co.) at 60 mg/kg was ad-
ministered i.p. Three days after administration, the rats’ 
glycemia was measured and those with blood glucose over 
250 mg/dL were considered as diabetic. The diabetic rats 
had diabetes symptoms such as polydipsia, diuresis, and 
weight loss.
After the diabetes was confirmed in the groups of interest, 
the animals were treated with the extract for one week. 
The animals were i.p administered with the extract at 
specified doses according to the grouping on a daily ba-
sis. Glycemia was measured and recorded at 3 steps, prior 
to STZ administration, after diabetes induction on a dai-
ly basis for one week, and at the completion of tests. All 
the animals were sacrificed with no suffering according 
to ethical principles of animal experimentation and their 
blood samples were collected. The level of serum insulin 
was measured by radioimmunoassay kit (Diasorin, Italy). 
The used kit was compatible with rats’ insulin. 
The data of studied groups were analyzed by SPSS and ex-
pressed as mean ± SEM. For comparison, one-way analysis 
of variance (ANOVA) was used and for inter-group com-
parisons Tukey test was used. The level of significance was 
considered P < 0.05.
Results
Seventy-two hours after STZ administration, glycemia 
increased significantly in the groups administered with 
STZ compared to the control group not receiving STZ 
(P < 0.001). Treatment with Satureja montanum  leaf hy-
droethanolic extract could significantly decrease glycemia 
in diabetic rats in a dose-dependent manner. 
These findings indicated that glycemia decreased signifi-
cantly in the diabetic rats treated with Satureja montanum 
leaf hydroethanolic extract at 200 mg/kg on day 5 com-
pared to the diabetized control group (P < 0.01). Moreover 
glycemia decreased significantly in the diabetic rats treat-
ed with Satureja montanum  leaf hydroethanolic extract 
at 400 and 800 mg/kg compared to the diabetic control 
group (P < 0.001). The difference in glycemia between the 
diabetic group treated with the extract at high dose and 
the control group was not significant, between metfor-
min-treated diabetic group and control group was signifi-
cant (P < 0.001), and between metformin-treated diabetic 
group and the groups treated with Satureja montanum 
Hypoglycemic effect of Satureja montanum extract
Journal of HerbMed Pharmacology, Volume 5, Number 1, January 2016http://www.herbmedpharmacol.com 19
leaf hydroethanolic extract at low and moderate doses was 
not significant. On the other hand, the difference between 
metformin-treated group and control group was derived 
significant (P < 0.001; Figure 1). 
These findings indicated that glycemia decreased signifi-
cantly in the diabetic rats treated with Satureja montanum 
leaf hydroethanolic extract at 200 mg/kg on day 6 com-
pared to the diabetic control group (P < 0.01). The differ-
ence remained significant compared to the control group 
(P < 0.001). Moreover, glycemia decreased significantly 
in the diabetic rats treated with Satureja montanum  leaf 
hydroethanolic extract at 400 or 800 mg/kg compared to 
the diabetic control group and the group treated with the 
extract at 200 mg/kg (P < 0.001), but the difference in gly-
cemia between the group treated with the extract at 400 
mg/kg and the control group with increased glycemia re-
mained significant (P < 0.001). The difference in glycemia 
between the diabetic group treated with the extract at high 
dose and the control group was not significant, between 
metformin-treated diabetic group and control group was 
significant (P < 0.001), and between metformin-treated 
diabetic group and the groups treated with Satureja mon-
tanum  leaf hydroethanolic extract at low and moderate 
doses was not significant. On the other hand, the differ-
ence between metformin-treated group and control group 
was derived significant (P < 0.001; Figure 2). 
These findings indicated that glycemia decreased signifi-
cantly in the diabetic rats treated with Satureja montanum 
leaf hydroethanolic extract at different doses on day 8 
were similar to day 6 (Figure 3). 
The variations in glycemia in any studied groups at dif-
ferent days indicated that Satureja montanum leaf hydro-
Figure 1. Comparison of glycemia in different groups at day 5 
of the study; mean ± standard error of measurement express the 
data of male Wistar rats (n = 6); * represents the significance 
of variation in glycemia of the animals in different groups after 
treatment in comparison to the control group (***P < 0.001); 
# represents the significance of variation in glycemia of the 
animals in different groups in comparison to the untreated 
diabetized group (## P < 0.01, ### P < 0.001); + represents the 
significance of variation in glycemia of the animals in different 
groups in comparison to the group administered with the extract 
at low dose (200 mg/kg) (++ P < 0.01, +++ P < 0.001).
Figure 2. Comparison of glycemia in different groups at day 6 
of the study; mean ± standard error of measurement express the 
data of male Wistar rats (n = 6); * represents the significance 
of variation in glycemia of the animals in different groups after 
treatment in comparison to the control group (*** P < 0.0001, 
* P < 0.05); # represents the significance of variation in glycemia 
of the animals in different groups in comparison to the untreated 
diabetized group (### P < 0.001); + represents the significance 
of variation in glycemia of the animals in different groups in 
comparison to the group administered with the extract at low 
dose (200 mg/kg) (+++ P < 0.001); $ represents the significance of 
variation in glycemia of the animals in the group administered with 
the extract at high dose (800 mg/kg) in comparison to those in the 
group administered with the extract at moderate dose (400 mg/
kg) (P < 0.05).
Figure 3. Comparison of glycemia in different groups at day 8 
of the study; mean ± standard error of measurement express the 
data of male Wistar rats (n = 6); * represents the significance 
of variation in glycemia of the animals in different groups after 
treatment in comparison to the control group (*** P < 0.001); # 
represents the significance of variation in glycemia of the animals 
in different groups in comparison to the untreated diabetized 
group (### P < 0.001); + represents the significance of variation 
in glycemia of the animals in different groups in comparison to 
the group administered with the extract at low dose (200 mg/kg) 
(+++ P < 0.001).
ethanolic extract caused a significant, dose-dependent de-
crease in glycemia in the rats. This decrease was obtained 
highest for metformin at day 6, and a significant increase 
in the rats’ glycemia was seen from day 7 afterwards com-
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pared to the groups treated with Satureja montanum leaf 
hydroethanolic extract at low, moderate, and high doses 
(P < 0.001; Figure 4). The variations in serum insulin in 
the groups treated with Satureja montanum leaf hydro-
ethanolic extract indicated that Satureja montanum  leaf 
hydroethanolic extract at 400 mg/kg caused no significant 
difference in the treated healthy group. However, Sat-
ureja montanum leaf hydroethanolic extract at 400 mg/kg 
caused a significant increase in serum insulin in diabetic 
group compared to the diabetic control group (P < 0.001). 
However the increase in insulin in this group decreased 
Figure 4. Comparison of glycemia in different groups at different 
days of the study. 
Figure 5. Comparison of serum insulin among control group, the 
group treated with extract at moderate dose, untreated diabetic 
group, and diabetic group treated with extract at moderate dose; 
mean ± standard error of measurement express the data of male 
Wistar rats (n = 6); * represents the significance of variation in 
serum insulin of the animals in groups in comparison to the control 
group (*** P < 0.001); # represents the significance of variation in 
serum insulin of the animals in different groups in comparison to 
the healthy, extract-treated group (### P < 0.001); + represents the 
significance of variation in serum insulin of the animals in different 
groups in comparison to diabetic, untreated group (200 mg/kg) 
(+++ P < 0.001).
significantly compared to the control group and the con-
trol group treated with the extract at 400 mg/kg (P < 0.001; 
Figure 5).
Discussion
The findings of this study indicated that i.p administration 
of Satureja montanum  hydroalcoholic extract in short-
term significantly affected the glycemia in the studied 
animals in a positive manner. Satureja montanum hydro-
ethanolic extract at low, moderate, and high doses caused 
a significant decrease blood glucose of the rats with STZ-
induced diabetes in a dose-dependent manner. 
The studies have indicated oxidative stress and inflamma-
tory damages are caused by hyperglycemic conditions in 
diabetes (16). The incidence of oxidative stress is higher 
in the patients with diabetes than the individuals in con-
trol group. The production rate of free radicals increases 
in the patients with diabetes while antioxidant resistance 
declines in them. As a result, oxidative stress increases 
in these patients (12). The induction of diabetes in rats 
caused decline in activity of antioxidant enzymes, super-
oxide dismutase and glutathione peroxidase, in the stud-
ied groups. Prolonged diabetes caused decline in catalase, 
glutathione reductase, GSH-Px and SOD (17).
In traditional medicine, Satureja montanum  is used as a 
supplement for patients with diabetes. Studies have indi-
cated that Satureja montanum  essence could decline free 
radicals (17,18). In addition, antioxidant, antimicrobial, 
and anti-inflammatory properties have been confirmed 
for Satureja montanum  (12,13,19). Containing several 
phenolic compounds with strong antioxidant and anti-
inflammatory effects, Satureja montanum  can reduce 
diabetes-derived oxidative stress. A study found that Sa-
tureja montanum exerted stronger antioxidant properties 
than Mentha piperita extract. Many studies have pointed 
to anti-inflammatory and antimicrobial properties of Sat-
ureja montanum (20).
A study has demonstrated that Satureja montanum  con-
tains mucilage compounds, resin, and tannin. Moreover 
limonene 1 and 8 and cineole are other single ring mono-
terpenes in Satureja montanum. Borneol and camphor 
have been reported as other monoterpenes in this plant 
(21). Antioxidant property of Satureja montanum ethanol 
extract, which is enhanced as the extract’s concentration 
increases, has been also demonstrated (22). Furthermore 
some studies have found that Satureja montanum essence’s 
antioxidant property is enhanced as its concentration in-
creases (23). 
Studies have indicated that there are phenolic monoter-
penes such as thymol, and gamma-terpinene in Satureja 
montanum. In addition, Satureja montanum  extract has 
been reported to contain carvacrol (24,25). A study has 
demonstrated that Satureja montanum  essence’ ability to 
prevent linoleic acid oxidation was very high and approxi-
mately equal to BTH’s (26).
In light of the present study’s and other studies’ findings, 
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Satureja montanum  could exert anti diabetic properties 
because of strong antioxidant and anti-inflammatory 
properties and suppressing oxidative stress following dia-
betes. As mentioned previously, as the Satureja montanum 
extract concentration increases, its antioxidant property 
is enhanced. This finding is consistent with the pres-
ent study as the Satureja montanum  extract anti diabetic 
property was enhanced with increase in its concentration. 
Hence Satureja montanum could prevent increase in gly-
cemia in the studied rats through high antioxidant and 
anti-inflammatory activity.
As mentioned above, Satureja montanum  antioxidant 
effects and hence high anti-inflammatory activity dem-
onstrated in several studies could contribute to diabe-
togenetic process of STZ and prevent its further effects, 
facilitating the process of recovery and rearrangement of 
insulin-producing cells. These findings demonstrated that 
the rate of insulin secretion in the diabetic animals treated 
with Satureja montanum  leaf extract increased signifi-
cantly compared to the diabetic group. Since the destruc-
tion of pancreatic islets beta cells and cell DNA is caused 
after STZ administration, the Satureja montanum extract 
is thought to contribute to protecting or repair damaged 
pancreas tissue against inflammation and necrosis due to 
STZ by increasing the activity of dismutase superoxide 
and glutation peroxidase, and therefore cell stimulation 
was furthered and pancreatic islets tissue was restored.
The findings of the present study indicated that Satureja 
montanum  could significantly affect the diabetes course 
and prevent increase in glycemia and insulin in STZ-dia-
betic adult male rats. However further and more advanced 
equipment lacking in the present study is needed to ex-
plain the cell and enzyme mechanisms, and further stud-
ies are strongly recommended to remove the limitations 
of the present study. Altogether, if the potentially involved 
mechanisms in this process are explained, Satureja mon-
tanum could be used as a strong anti-diabetic medication 
and/or natural anti diabetic drugs with fewer side effects 
could be supplemented by extraction of Satureja monta-
num  effective compounds.
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